Neotigason 10 mg tvrde kapsule Horvātija - horvātu - HALMED (Agencija za lijekove i medicinske proizvode)

neotigason 10 mg tvrde kapsule

teva b.v., swensweg 5, haarlem, nizozemska - acitretin - kapsula, tvrda - 10 mg - urbroj: jedna tvrda kapsula sadrži 10 mg acitretina

Neotigason 25 mg tvrde kapsule Horvātija - horvātu - HALMED (Agencija za lijekove i medicinske proizvode)

neotigason 25 mg tvrde kapsule

teva b.v., swensweg 5, haarlem, nizozemska - acitretin - kapsula, tvrda - 25 mg - urbroj: jedna tvrda kapsula sadrži 25 mg acitretina

LONSURF 15mg + 6.14mg Film tableta Melnkalne - horvātu - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

lonsurf 15mg + 6.14mg film tableta

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - trifluridin, tipiracil - film tableta - 15mg + 6.14mg

LONSURF 15mg + 6.14mg Film tableta Melnkalne - horvātu - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

lonsurf 15mg + 6.14mg film tableta

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - trifluridin, tipiracil - film tableta - 15mg + 6.14mg

LONSURF 20mg + 8.19mg Film tableta Melnkalne - horvātu - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

lonsurf 20mg + 8.19mg film tableta

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - trifluridin, tipiracil - film tableta - 20mg + 8.19mg

LONSURF 20mg + 8.19mg Film tableta Melnkalne - horvātu - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

lonsurf 20mg + 8.19mg film tableta

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - trifluridin, tipiracil - film tableta - 20mg + 8.19mg

Qinlock Eiropas Savienība - horvātu - EMA (European Medicines Agency)

qinlock

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - tumori gastrointestinalnog stroma - antineoplastična sredstva - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.